Canada Markets closed

Piedmont Lithium Inc. (PLL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
57.84-2.04 (-3.41%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close59.88
Open60.20
Bid58.00 x 1000
Ask60.00 x 800
Day's Range57.55 - 60.27
52 Week Range23.56 - 88.97
Volume269,955
Avg. Volume305,480
Market Cap910.951M
Beta (5Y Monthly)0.46
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • Business Wire

    Piedmont Lithium Releases Updated Corporate Presentation for November 2021

    NEW YORK, November 10, 2021--Piedmont Lithium Inc., ("Piedmont" or the "Company") (NASDAQ: PLL; ASX: PLL), a leading developer of lithium hydroxide production to enable the North American electric vehicle supply chain, today released a new Corporate Overview Presentation. The updated presentation includes information addressing overall market conditions, lithium supply and demand projections from industry analysts, pricing trends, as well as a status update on Piedmont’s multiple resources in No

  • Business Wire

    Monique Parker Chosen to Lead Piedmont Lithium Health, Safety, and Environment

    NEW YORK, October 28, 2021--Piedmont Lithium Inc., ("Piedmont" or the "Company") (NASDAQ: PLL; ASX: PLL), a leading developer of lithium hydroxide production to enable the North American electric vehicle supply chain, today announced that Monique Parker has joined the Company as Vice President of Health, Safety, and Environment. Reporting to Chief Operating Officer, David Klanecky, Ms. Parker brings more than a decade of experience managing environmental, health and safety operations for some of

  • GlobeNewswire

    Bragar Eagel & Squire is Investigating Certain Officers and Directors of Provention Bio, Danimer Scientific, AcelRX, and Piedmont Lithium on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

    NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Provention Bio, Inc. (NASDAQ: PRVB), Danimer Scientific, Inc. (NYSE: DNMR), AcelRX Pharmaceuticals, Inc. (NASDAQ: ACRX), and Piedmont Lithium Inc. (NASDAQ: PLL) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. Provention Bio, Inc. (NASDAQ: PRVB) Bragar Eage